G. Mark Latham

Statistics

Publications

Citations

H-Index

Active since

1997

Affiliations

Idera Pharmaceuticals (United States)(Current)

G. Mark Latham is an author at Idera Pharmaceuticals (United States) specializing in medicinal chemistry, molecular virology, and synthetic medicinal chemistry.

Publications per year

1997–2014

Publications

Development of Related HCV Protease Inhibitors: Macrocyclization of Two Highly Functionalized Dienyl-ureas via Ring-Closing Metathesis

Arumugasamy Jeevanandam, Arunachalam Kannan, David Bauer et al. · Organic Process Research & Development · 2013 · 27 citations

Pharmacy, Medicinal Chemistry, Drug Discovery +12

Robust Synthesis of Methyl 5-Chloro-4-fluoro-1H-indole-2-carboxylate: A Key Intermediate in the Preparation of an HIV NNRTI Candidate

Benjamin A. Mayes, Narayan C. Chaudhuri, Christopher P. Hencken et al. · Organic Process Research & Development · 2010 · 12 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Synthesis of a Nucleoside Phosphoramidate Prodrug Inhibitor of HCV NS5B Polymerase: Phenylboronate as a Transient Protecting Group

Benjamin A. Mayes, Arumugasamy Jeevanandam, Erkan Baloglu et al. · Organic Process Research & Development · 2014 · 12 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +17

The preparation of N‐(1H‐pyrazol‐3‐yl)arylamides and 1H‐pyrazol‐3‐amines from polylithiated C(α),N‐thiosemicarbazones and C(α),N‐semicarbazones

Charles F. Beam, Sharon E. Davis, Tracy L. Cordray et al. · Journal of Heterocyclic Chemistry · 1997 · 11 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

1–4 of 4